{"organizations": [], "uuid": "c494e6ae7363035664fac68cfa69a66d4dccdde5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-acerus-reports-q4-loss-per-share-0/brief-acerus-reports-q4-loss-per-share-0-01-idUSASC09T40", "country": "US", "domain_rank": 408, "title": "BRIEF-Acerus Reports Q4 Loss Per Share $0.01", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-21T12:04:00.000+02:00", "replies_count": 0, "uuid": "c494e6ae7363035664fac68cfa69a66d4dccdde5"}, "author": "", "url": "https://www.reuters.com/article/brief-acerus-reports-q4-loss-per-share-0/brief-acerus-reports-q4-loss-per-share-0-01-idUSASC09T40", "ord_in_thread": 0, "title": "BRIEF-Acerus Reports Q4 Loss Per Share $0.01", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - acerus pharmaceuticals corporation", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 21, 2018 / 10:05 AM / Updated 13 minutes ago BRIEF-Acerus Reports Q4 Loss Per Share $0.01 Reuters Staff March 21 (Reuters) - Acerus Pharmaceuticals Corporation : * ACERUS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS * Q4 LOSS PER SHARE $0.01 * TOTAL Q4 REVENUES INCREASED TO $2.1 MILLION FROM $1.8 MILLION IN SAME PRIOR YEAR PERIOD Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-21T12:04:00.000+02:00", "crawled": "2018-03-21T12:22:46.002+02:00", "highlightTitle": ""}